CLOV

Over the past six months, Clover Health's stock price has been influenced by several key events. In January 2026, the company announced a significant 53% year-over-year membership growth in its Medicare Advantage PPO plans and projected its first full-year GAAP Net Income profitability in 2026, which caused the stock to soar by 10%. In February 2026, Clover Health reported its fourth-quarter and full-year 2025 results, reiterating its path to GAAP Net Income profitability, leading to stock price fluctuations around these announcements. In March 2026, the company announced a planned CFO transition while reaffirming its full-year 2026 financial guidance. On May 6, 2026, Clover Health reported its first-quarter 2026 results, showing a return to GAAP profitability with a net income of $27 million and a 62% year-over-year revenue increase to $749 million, although its EPS of $0.05 fell short of analyst expectations. This report led to a modest increase in the stock price. Despite these positive developments, the stock experienced general declines, with a 47.55% decrease between April 2025 and April 2026. As of May 8, 2026, the share price was $3.11, representing an 11.40% decline over the past year.